JAN 27, 2017 04:00 AM PST

WEBINAR: Highly Multiplexed Single Cell Analysis Of Tumor Heterogeneity Through Time and Space by Mass Cytometry

Speakers
  • Professor for Quantitative Biology, University of Zurich
    Biography
      Bernd Bodenmiller (1979) studied biochemistry at the University of Bayreuth and ETH Zürich and obtained his PhD for his work on system-wide signaling network analysis in the laboratory of Ruedi Aebersold at ETH Zürich. For his postdoctoral training, he joined the laboratory of Garry P. Nolan at Stanford University. There he developed methods for the high throughput analysis of signaling network states by mass cytometry, a technology that allows in principle to quantify 135 proteins and signaling molecules at the single cell level. In 2012, he became group leader and in 2013 SNF/ERC assistant professor at the Institute of Molecular Life Sciences at the University of Zürich. Currently his group is developing methods for highly multiplexed imaging by mass cytometry (Giesen et al, Nature Methods, 2014) to unravel how trans-cellular signaling network interactions in the tumor microenvironment drive cancer development and ultimately might be exploited for therapeutic targeting.
    • Director, Cytometry, Cell Signaling Technology
      Biography
        Dr. Wetzel has been at Cell Signaling Technology for 15 years and currently leads the antibody testing and validation team, the antibody conjugation team, and an assay development team specializing in ELISA, bead assay, and multiplex IHC kits. His areas of expertise include: wide-field, confocal, and spectral fluorescent microscopy, automated high content imaging, flow cytometry, novel dye and conjugation chemistry, and sandwich assay (bead, ELISA, alpha) development.

      Abstract:

      DATE: January 27, 2017
      TIME: 4:00am PT, 7:00am ET, 1:00pm CET

      The study of the tumor ecosystem and its cell-to-cell communications is essential to enable an understanding of tumor biology, to define new biomarkers to improve patient care, and ultimately to identify new therapeutic routes and targets.

      To study and understand the workings of the tumor ecosystem (TME), highly multiplexed image information of tumor tissues is essential. Such multiplexed images will reveal which cell types are present in a tumor, their functional state, and which cell-cell interactions are present. To enable multiplexed tissue imaging, we developed imaging mass cytometry (IMC). IMC is a novel imaging modality that uses metal isotopes of defined mass as reporters on antibodies and currently allows the visualization of over 50 proteins simultaneously on tissues with subcellular resolution. In the near future, we expect to be able to visualize over 100 proteins. Thus highly specific, reproducible and deeply validated antibodies are essential for IMC and any multiplexed antibody based method.
       
      We applied IMC for the analysis of hundreds of breast cancer samples in a quantitative manner. Our analysis with a novel computational pipeline reveals a surprising level of inter and intra-tumor heterogeneity and identified new diversity within known human breast cancer subtypes, as well as a variety of stromal cell types that interact with them. Furthermore, we identified cell-cell interaction motifs in the tumor microenvironment correlating with clinical outcomes of the analyzed patients.
       
      In summary, our results show that IMC provides targeted, high-dimensional analysis of cell type, cell state and cell-to-cell interactions within the TME at subcellular resolution. Spatial relationships of complex cell states of cellular assemblies can be used as biomarkers. We envision that IMC will enable a systems biology approach to understand and diagnose disease and to guide treatment.

      Learning Objectives:

      • Learn about the novel imaging technique imaging mass cytometry (IMC)
      • Understand how antibody quality impacts highly multiplexed techniques

      Show Resources
      You May Also Like
      AUG 27, 2019 09:00 AM PDT
      C.E. CREDITS
      AUG 27, 2019 09:00 AM PDT
      DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
      OCT 02, 2019 11:00 AM PDT
      OCT 02, 2019 11:00 AM PDT
      DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
      JUN 05, 2019 05:00 PM CEST
      C.E. CREDITS
      JUN 05, 2019 05:00 PM CEST
      DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
      MAY 16, 2019 04:00 PM CEST
      C.E. CREDITS
      MAY 16, 2019 04:00 PM CEST
      DATE: May 16, 2019TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST The emergence of NGS is revolutionizing the microbiological sciences and transforming medicine. Deep sequencing has...
      NOV 18, 2019 07:00 AM PST
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      C.E. CREDITS
      NOV 18, 2019 07:00 AM PST
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      DATE: November 18, 2019TIME: 7:00am PST, 11:00am EST, 4:00pm CEWT How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop th...
      AUG 13, 2019 09:00 AM PDT
      C.E. CREDITS
      AUG 13, 2019 09:00 AM PDT
      DATE: August 13, 2019TIME: 9:00am PT, 12:00pm ET, 5:00pm BST Molecular complexes are major constituents of cells, hence unraveling their mechanisms is key to fuller comprehension of c...
      Loading Comments...
      Show Resources